Alliancebernstein L.P. Durect Corp Transaction History

Alliancebernstein L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $7,296 - $12,288	-19,200 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.55 - $0.98 $55 - $98	100 Added 0.52%	19,200 $13,000
Q3 2021 Nov 10, 2021	SELL	$1.21 - $1.61 $5,929 - $7,889	-4,900 Reduced 20.42%	19,100 $24,000
Q2 2021 Jul 30, 2021	BUY	$1.6 - $2.02 $9,120 - $11,514	5,700 Added 31.15%	24,000 $39,000
Q1 2021 May 06, 2021	SELL	$1.86 - $2.87 $24,552 - $37,884	-13,200 Reduced 41.9%	18,300 $36,000
Q4 2020 Feb 08, 2021	SELL	$1.65 - $2.43 $12,540 - $18,468	-7,600 Reduced 19.44%	31,500 $65,000
Q3 2020 Nov 12, 2020	SELL	$1.6 - $2.35 $43,520 - $63,920	-27,200 Reduced 41.03%	39,100 $67,000
Q2 2020 Aug 13, 2020	BUY	$1.33 - $2.76 $88,179 - $182,988	66,300 New	66,300 $154,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $12,087 - $20,382	-23,700 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$0.51 - $0.82 $5,610 - $9,020	-11,000 Reduced 31.7%	23,700 $15,000
Q2 2018 Aug 13, 2018	BUY	$1.56 - $2.51 $20,592 - $33,132	13,200 Added 61.4%	34,700 $54,000
Q4 2017 Feb 13, 2018	SELL	$0.78 - $2.1 $8,034 - $21,630	-10,300 Reduced 32.39%	21,500 $20,000
Q3 2017 Nov 13, 2017	BUY	$1.55 - $1.82 $49,290 - $57,876	31,800	31,800 $56,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.